[1]邵永康.维持性血液透析患者并发症的发病机制分析[J].医学信息,2019,(17):35-38.[doi:10.3969/j.issn.1006-1959.2019.17.012]
 SHAO Yong-kang.Pathogenesis Analysis of Complications in Maintenance Hemodialysis Patients[J].Medical Information,2019,(17):35-38.[doi:10.3969/j.issn.1006-1959.2019.17.012]
点击复制

维持性血液透析患者并发症的发病机制分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年17期
页码:
35-38
栏目:
综述
出版日期:
2019-09-01

文章信息/Info

Title:
Pathogenesis Analysis of Complications in Maintenance Hemodialysis Patients
文章编号:
1006-1959(2019)17-0035-04
作者:
邵永康
天津市公安医院检验科,天津 300050
Author(s):
SHAO Yong-kang
Department of Clinical Laboratory,Tianjin Public Security Hospital,Tianjin 300050,China
关键词:
透析并发症发病机制肾衰竭
Keywords:
Key words:Dialysis complicationsPathogenesisRenal failure
分类号:
R692.5
DOI:
10.3969/j.issn.1006-1959.2019.17.012
文献标志码:
A
摘要:
肾脏综合症并发急性肾衰竭是临床治疗棘手的疾病之一,其重症阶段主要体现为心血管疾病及相关并发症。维持性血液透析是该病的有效方法之一,但透析的并发症较多,且风险较大。本文着重对透析并发症的发病机制进行研究,并分析了高血压、低血压、失衡综合征、贫血、发热、心律失常和心力衰竭等并发症的典型症状,目的是减少透析并发症的发生,减轻患者痛苦,提高其生活质量,延长血液透析患者的存活率。
Abstract:
Abstract:Renal syndrome acute renal failure is one of the most difficult diseases in clinical treatment. The severe stage is mainly manifested in cardiovascular diseases and related complications. Maintenance hemodialysis is one of the effective methods to treat such diseases, but dialysis has more complications and risks. This article focuses on the analysis of the pathogenesis of dialysis complications, and lists typical symptoms of complications such as hypertension, hypotension, imbalance syndrome, anemia, fever, arrhythmia and heart failure, with the aim of reducing the incidence of dialysis complications and reducing patients suffer, improve their quality of life, and prolong the survival rate of hemodialysis patients.

参考文献/References:

[1]李勇.连续性肾脏替代疗法对治疗肾病综合征合并急性肾衰竭的效果分析[J].新疆医学,2016,46(5):541-543. [2]潘志家.连续性肾脏替代治疗方法治疗老年多器官功能障碍综合征的疗效与安全性[J].吉林医学,2019,40(5):987-988. [3]刘欢,陶雅非,任东升,等.血浆透析联合腹膜透析治疗对尿毒症患者营养状况,心肾功能及并发症的影响[J].山东医药,2019,59(14):63-65. [4]张渊, 孟祥龙,洪大情,等.维持性血液透析患者透析充分性与肾性贫血的关系[J].中国血液净化,2014,13(4):311-312. [5]张国娟,陈燊,黄雯.中性粒细胞淋巴细胞比值在评价慢性肾脏病患者炎症状态中的作用[J].中国血液净化,2015,14(8):482-485. [6]姜延新.不同剂量促红细胞生成素在对肾性贫血治疗的临床研究[J].黑龙江医学,2018,42(11):1080-1081. [7]樊迪,路万虹,杨悦,等.促红细胞生成素及铁剂治疗肾性贫血的合理性评价[J].西北药学杂志,2016,31(3):305-308. [8]孙劲秋,郭恩绵.郭恩绵多途径治疗慢性肾衰竭[J].实用中医内科杂志,2015,29(9):8-11. [9]陈延芳,王逸申.糖尿病肾病所致终末期肾病维持性血液透析患者高血压的多中心临床研究[J].上海医学,2017,40(1):26-30. [10]李宁.甲状旁腺激素在尿毒症中诱导血管内皮细胞间质转化的作用和机制研究[D].第三军医大学,2014. [11]周宓.血液透析患者红细胞分布宽度与患者低血压及心血管事件的关系[J].中国卫生检验杂志,2017,27(12):1752-1754. [12]邱金英,李璐.维持性血液透析患者透析中低血压相关因素的分析[J].赣南医学院学报,2016,36(1):104-105. [13]施翊,章海芬,方妮娜,等.维持性血液透析患者血压与人体成分分析的相关性研究[J].中国血液净化,2018,17(9):593-597. [14]陈鹤,张敏,赵燕.不同分期的慢性肾脏疾病患者贫血及铁代谢指标的研究分析[J].临床输血与检验,2018,20(5):518-521. [15]Daniel I,Sessler J,Bloomstone S,et al.Perioperative Quality Initiative consensus statement on intraoperative blood pressure,risk and outcomes for elective surgery[J].British Journal of Anaesthesia,2019,122(5):563-574. [16]张瑜琪.血液透析失衡综合征的危险因素及防治分析[J].齐齐哈尔医学院学报,2016,37(34):4283-4284. [17]刘晶晶.护理干预对长期血液透析患者透析失衡综合征的效果[J].中国医药指南,2017,16(15):240-241. [18]徐毅.慢性肾小球肾炎与糖尿病肾病维持性血液透析患者贫血的临床分析[J].吉林医学,2018,39(10):1955-1956. [19]Elsheikh N,Sherif N,Zeid SA,et al.The link between bone disease and cardiovascular complications in hemodialysis patients[J].Electronic Physician,2016,8(6):2483-2488. [20]马涛,董一兰.慢性肾衰患者血液透析并发心律失常类型及致病因素的临床探讨[J].中西医结合血管病电子杂志,2018,24(6):69-70. [21]Morfin JA,Fluck RJ,Weinhandl ED,et al.Intensive Hemodialysis and Treatment Complications and Tolerability[J].Am J Kidney Dis.,2016,68(5S1):S43-S50. [22]陈依特,杨伟鹏,陈旋.长期维持性血液透析慢性肾功能衰竭患者发生并发症危险因素分析[J].内蒙古医学杂志,2019,51(3):316-317. [23]宋延云.血液透析常见并发症的发生原因分析及防治措施[J].中国医药导报,2017,12(9):173-174. [24]沈永侠.不同给药途径应用重组人红细胞生成素治疗血液透析患者肾性贫血的疗效与安全性[J].医药前沿,2015,5(31):107-108. [25]蒲辉,周红丽.血液透析联合血液灌流治疗尿毒症顽固性高血压疗效分析[J].中国中西医结合肾病杂志,2019,20(2):161-162. [26]Chirakarnjanakorn S,Navaneethan SD,Francis GS,et al.Cardiovascular impact in patients undergoing maintenance hemodialysis:Clinical management considerations[J].International Journal of Cardiology,2017(232):12-23. [27]Kritchevsky SB,Tooze JA,Neiberg RH,et al.25Hydroxyvitamin D,parathyroid hormone and mortalityin black and white older adults:the health ABC study[J].J Clin Endocrinol Metab,2015,97(11):4156-4165.

相似文献/References:

[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
 LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Medical Information,2018,(17):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]王玉霞.剖宫产术后子宫疤痕妊娠的临床诊治[J].医学信息,2018,(10):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
 WANG Yu-xia.Clinical Diagnosis and Treatment of Uterine Scar Pregnancy after Cesarean Section[J].Medical Information,2018,(17):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
[3]王煜婷.原发性痛经发病机制及口服药物治疗进展[J].医学信息,2018,(13):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
 WANG Yu-ting.Research Progress in Pathogenesis and Oral Medication of Primary Dysmenorrhea[J].Medical Information,2018,(17):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
[4]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
 ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Medical Information,2018,(17):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[5]马宏境,刘 彬.慢性阻塞性肺疾病发病机制的研究[J].医学信息,2019,(10):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
 MA Hong-jing,LIU Bin.Study on the Pathogenesis of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,(17):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]

更新日期/Last Update: 2019-09-01